Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2474

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years ; volume:21 ; number:1 ; day:3 ; month:12 ; year:2020 ; pages:1-11 ; date:12.2020
BMC musculoskeletal disorders ; 21, Heft 1 (3.12.2020), 1-11, 12.2020

Creator: Lo, Joan C.
Neugebauer, Romain S.
Ettinger, Bruce
Chandra, Malini
Hui, Rita L.
Ott, Susan M.
Grimsrud, Christopher D.
Izano, Monika A.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12891-020-03672-w

URN: urn:nbn:de:101:1-2021011218272709672583

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lo, Joan C.
Neugebauer, Romain S.
Ettinger, Bruce
Chandra, Malini
Hui, Rita L.
Ott, Susan M.
Grimsrud, Christopher D.
Izano, Monika A.
SpringerLink (Online service)

Other Objects (12)

$Atypical femur fracture in a male without history of bisphosphonate use: a case report$

Atypical femur fracture in a male without history of bisphosphonate use: a case report

$Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy$

Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

$Severe atypical iliac wing fracture associated with long-term bisphosphonate use$

Severe atypical iliac wing fracture associated with long-term bisphosphonate use

Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture

$Atypical femoral fractures related to bisphosphonate therapy$

Atypical femoral fractures related to bisphosphonate therapy

$Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report$

Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report

$Bisphosphonate use after clinical fracture and risk of new fracture$

Bisphosphonate use after clinical fracture and risk of new fracture

$Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system$

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system

Letter to the Editor: Missing Information and Bias Confounds Relationship Between Manipulation and Atypical Femur Fracture

The Genetics of Atypical Femur Fractures—a Systematic Review

$Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment$

Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment

$Atypical femur fracture in a male without history of bisphosphonate use: a case report$

Atypical femur fracture in a male without history of bisphosphonate use: a case report

$Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy$

Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

$Severe atypical iliac wing fracture associated with long-term bisphosphonate use$

Severe atypical iliac wing fracture associated with long-term bisphosphonate use

Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture

$Atypical femoral fractures related to bisphosphonate therapy$

Atypical femoral fractures related to bisphosphonate therapy

$Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report$

Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report

$Bisphosphonate use after clinical fracture and risk of new fracture$

Bisphosphonate use after clinical fracture and risk of new fracture

$Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system$

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system

Letter to the Editor: Missing Information and Bias Confounds Relationship Between Manipulation and Atypical Femur Fracture

The Genetics of Atypical Femur Fractures—a Systematic Review

$Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment$

Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment

$Atypical femur fracture in a male without history of bisphosphonate use: a case report$

Atypical femur fracture in a male without history of bisphosphonate use: a case report

$Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy$

Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

$Severe atypical iliac wing fracture associated with long-term bisphosphonate use$

Severe atypical iliac wing fracture associated with long-term bisphosphonate use

Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture

$Atypical femoral fractures related to bisphosphonate therapy$

Atypical femoral fractures related to bisphosphonate therapy

$Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report$

Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report

$Bisphosphonate use after clinical fracture and risk of new fracture$

Bisphosphonate use after clinical fracture and risk of new fracture

$Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system$

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system

Letter to the Editor: Missing Information and Bias Confounds Relationship Between Manipulation and Atypical Femur Fracture

The Genetics of Atypical Femur Fractures—a Systematic Review

$Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment$

Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Atypical femur fracture in a male without history of bisphosphonate use: a case report

Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

Severe atypical iliac wing fracture associated with long-term bisphosphonate use

Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture

Atypical femoral fractures related to bisphosphonate therapy

Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report

Bisphosphonate use after clinical fracture and risk of new fracture

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system

Letter to the Editor: Missing Information and Bias Confounds Relationship Between Manipulation and Atypical Femur Fracture

The Genetics of Atypical Femur Fractures—a Systematic Review

Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment

Atypical femur fracture in a male without history of bisphosphonate use: a case report

Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

Severe atypical iliac wing fracture associated with long-term bisphosphonate use

Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture

Atypical femoral fractures related to bisphosphonate therapy

Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report

Bisphosphonate use after clinical fracture and risk of new fracture

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system

Letter to the Editor: Missing Information and Bias Confounds Relationship Between Manipulation and Atypical Femur Fracture

The Genetics of Atypical Femur Fractures—a Systematic Review

Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment

Atypical femur fracture in a male without history of bisphosphonate use: a case report

Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

Severe atypical iliac wing fracture associated with long-term bisphosphonate use

Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture

Atypical femoral fractures related to bisphosphonate therapy

Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report

Bisphosphonate use after clinical fracture and risk of new fracture

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system

Letter to the Editor: Missing Information and Bias Confounds Relationship Between Manipulation and Atypical Femur Fracture

The Genetics of Atypical Femur Fractures—a Systematic Review

Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment

Related objects

Reset password